MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.524
+0.024 (4.76%)
Dec 20, 2024, 4:00 PM EST - Market closed
MiNK Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | - | - | - | 0.69 |
| Gross Profit | - | - | - | - | - | 0.69 |
| Selling, General & Admin | 5.69 | 7.43 | 7.83 | 4.64 | 1.29 | 3.83 |
| Research & Development | 8.24 | 15.49 | 23.12 | 13.97 | 9.51 | 19.65 |
| Operating Expenses | 14.29 | 22.92 | 30.95 | 18.61 | 10.8 | 23.48 |
| Operating Income | -14.29 | -22.92 | -30.95 | -18.61 | -10.8 | -22.79 |
| Interest Expense | - | - | - | -2.43 | -2.44 | -1.56 |
| Interest & Investment Income | 0.17 | 0.46 | 0.25 | - | - | - |
| Currency Exchange Gain (Loss) | - | - | - | -0.41 | 0.49 | 0.04 |
| Other Non Operating Income (Expenses) | 0.15 | -0 | -0.09 | 0.63 | 0.35 | 0 |
| EBT Excluding Unusual Items | -13.97 | -22.46 | -30.78 | -20.82 | -12.4 | -24.31 |
| Other Unusual Items | - | - | 2.79 | -9.4 | -3.84 | 0.51 |
| Pretax Income | -13.78 | -22.46 | -27.99 | -30.21 | -16.24 | -23.8 |
| Net Income | -13.78 | -22.46 | -27.99 | -30.21 | -16.24 | -23.8 |
| Net Income to Common | -13.78 | -22.46 | -27.99 | -30.21 | -16.24 | -23.8 |
| Shares Outstanding (Basic) | 36 | 34 | 34 | 26 | 24 | 24 |
| Shares Outstanding (Diluted) | 36 | 34 | 34 | 26 | 24 | 24 |
| Shares Change (YoY) | 6.74% | 2.04% | 29.38% | 7.95% | 0.20% | - |
| EPS (Basic) | -0.38 | -0.65 | -0.83 | -1.16 | -0.67 | -0.99 |
| EPS (Diluted) | -0.38 | -0.65 | -0.83 | -1.16 | -0.67 | -0.99 |
| Free Cash Flow | -10.86 | -15.84 | -19.12 | -13.08 | -8.43 | -15.37 |
| Free Cash Flow Per Share | -0.30 | -0.46 | -0.57 | -0.50 | -0.35 | -0.64 |
| Gross Margin | - | - | - | - | - | 100.00% |
| Operating Margin | - | - | - | - | - | -3305.06% |
| Profit Margin | - | - | - | - | - | -3451.46% |
| Free Cash Flow Margin | - | - | - | - | - | -2228.86% |
| EBITDA | -14.07 | -22.72 | -30.83 | -18.53 | -10.74 | -22.76 |
| D&A For EBITDA | 0.22 | 0.2 | 0.12 | 0.08 | 0.06 | 0.04 |
| EBIT | -14.29 | -22.92 | -30.95 | -18.61 | -10.8 | -22.79 |
Source: S&P Capital IQ. Standard template.
Financial Sources.